Evidence map›Paper›PMID 42675065›Full record

ArticleNature communications2026

Divergent concerted and stepwise cycloadditions via enantioselective cross-conjugated iminium-ion catalysis.

Erlaitz Basabe Obregón, Ida Rygaard Kocemba, Chi Zhang, Mikk Kaasik, Metin Cakiroglu, Philipp Waser, Pan-Pan Chen, K N Houk, Karl Anker Jørgensen

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Erlaitz Basabe Obregón *Department of Chemistry, Aarhus University, Aarhus C, Denmark.ORCID http://orcid.org/0000-0002-3723-6776
Ida Rygaard Kocemba *Department of Chemistry, Aarhus University, Aarhus C, Denmark.
Chi Zhang *Department of Chemistry and Biochemistry, University of California, Los Angeles, CA, US.
Mikk KaasikDepartment of Chemistry, Aarhus University, Aarhus C, Denmark.
Metin CakirogluDepartment of Chemistry, Aarhus University, Aarhus C, Denmark.
Philipp WaserDepartment of Chemistry, Aarhus University, Aarhus C, Denmark.
Pan-Pan ChenDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA, US.
K N HoukDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA, US. houk@g.ucla.edu.
Karl Anker JørgensenDepartment of Chemistry, Aarhus University, Aarhus C, Denmark. kaj@chem.au.dk.ORCID http://orcid.org/0000-0002-3482-6236

Funding

Novo Nordisk Fonden (Novo Nordisk Foundation) NNF 21OC0072047Villum Fonden (Villum Foundation) 25867
6 · The paper itself

Abstract

Cycloadditions are described as either concerted or stepwise processes, where a catalyst can influence both the mechanism and the peri-, regio- and stereoselectivity. We report experimental and DFT-computational investigations that reveal the versatile reactivities of cross-conjugated unsaturated iminium-ion intermediates. These undergo cycloadditions with cyclic and linear dienes via both stepwise and concerted pathways, respectively, providing two distinct classes of enantioenriched cycloadducts. Activation of 2-formyl-1,3-cyclohexadiene with a chiral 1,2-diaminocatalyst generates an acyclic cross-conjugated iminium-ion intermediate, which by utilizing 4π-electrons, undergoes enantioselective inverse-electron-demand [4 + 2] cycloadditions with cyclic dienes via a stepwise mechanism, as well as indene and a styrene, affording cycloadducts in high yields and up to 96% ee. In contrast, only 2π-electrons of the cross-conjugated iminium-ion intermediate are involved in the [4 + 2] cycloaddition with linear dienes, proceeding via an ambimodal asynchronous concerted pathway, yielding decalin derivatives in up to 96% ee. The generality of this catalytic enantioselective concept is expanded to also include acyclic cross-conjugated iminium-ion intermediates, which react with both cyclic and linear dienes following the same two distinct reaction pathways. In contrast, the analogous iminium-ion, generated from 1-formylcyclohexene, does not react under the same conditions.

Identifiers

PMID42675065
PMCPMC13530200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.